BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29680259)

  • 1. Low Incidence of Esophageal Toxicity After Lung Stereotactic Body Radiation Therapy: Are Current Esophageal Dose Constraints Too Conservative?
    Yau V; Lindsay P; Le L; Lau A; Wong O; Glick D; Bezjak A; Cho BCJ; Hope A; Sun A; Giuliani M
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(3):574-580. PubMed ID: 29680259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.
    Duijm M; van der Voort van Zyp NC; van de Vaart P; Oomen-de Hoop E; Mast ME; Hoogeman MS; Nuyttens JJ
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):73-81. PubMed ID: 31499137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal dose tolerance to hypofractionated stereotactic body radiation therapy: risk factors for late toxicity.
    Stephans KL; Djemil T; Diaconu C; Reddy CA; Xia P; Woody NM; Greskovich J; Makkar V; Videtic GM
    Int J Radiat Oncol Biol Phys; 2014 Sep; 90(1):197-202. PubMed ID: 25015204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Esophageal Dose Tolerance in Patients Treated With Stereotactic Body Radiation Therapy.
    Nuyttens JJ; Moiseenko V; McLaughlin M; Jain S; Herbert S; Grimm J
    Semin Radiat Oncol; 2016 Apr; 26(2):120-8. PubMed ID: 27000508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Esophagus toxicity after stereotactic and hypofractionated radiotherapy for central lung tumors: Normal tissue complication probability modeling.
    Duijm M; Tekatli H; Oomen-de Hoop E; Verbakel W; Schillemans W; Slotman BJ; Senan S; Nuyttens JJ
    Radiother Oncol; 2018 May; 127(2):233-238. PubMed ID: 29478763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor Control and Toxicity after SBRT for Ultracentral, Central, and Paramediastinal Lung Tumors.
    Nguyen KNB; Hause DJ; Novak J; Monjazeb AM; Daly ME
    Pract Radiat Oncol; 2019 Mar; 9(2):e196-e202. PubMed ID: 30496842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and Late Esophageal Toxicity After SABR to Thoracic Tumors Near or Abutting the Esophagus.
    Sodji QH; Ko R; von Eyben R; Owen SG; Capaldi DPI; Bush K; Binkley MS; Alrowais F; Pickthorn B; Maxim PG; Gensheimer MF; Diehn M; Loo BW
    Int J Radiat Oncol Biol Phys; 2022 Apr; 112(5):1144-1153. PubMed ID: 34942312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric predictors of esophageal toxicity after stereotactic body radiotherapy for central lung tumors.
    Wu AJ; Williams E; Modh A; Foster A; Yorke E; Rimner A; Jackson A
    Radiother Oncol; 2014 Aug; 112(2):267-71. PubMed ID: 25064471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic body radiotherapy for central lung tumors.
    Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
    J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation-induced brachial plexus toxicity after SBRT of apically located lung lesions.
    Lindberg K; Grozman V; Lindberg S; Onjukka E; Lax I; Lewensohn R; Wersäll P
    Acta Oncol; 2019 Aug; 58(8):1178-1186. PubMed ID: 31066326
    [No Abstract]   [Full Text] [Related]  

  • 11. Carotid Dosimetry and the Risk of Carotid Blowout Syndrome After Reirradiation With Head and Neck Stereotactic Body Radiation Therapy.
    Gebhardt BJ; Vargo JA; Ling D; Jones B; Mohney M; Clump DA; Ohr JP; Ferris RL; Heron DE
    Int J Radiat Oncol Biol Phys; 2018 May; 101(1):195-200. PubMed ID: 29398127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and dosimetric predictors of radiation-induced esophageal toxicity.
    Maguire PD; Sibley GS; Zhou SM; Jamieson TA; Light KL; Antoine PA; Herndon JE; Anscher MS; Marks LB
    Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):97-103. PubMed ID: 10477012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Control and Toxicity for Common Stereotactic Body Radiation Therapy Dose-Fractionation Regimens in Stage I Non-Small Cell Lung Cancer.
    Stephans KL; Woody NM; Reddy CA; Varley M; Magnelli A; Zhuang T; Qi P; Videtic GMM
    Int J Radiat Oncol Biol Phys; 2018 Feb; 100(2):462-469. PubMed ID: 29353658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of toxicity associated with stereotactic body radiation therapy to the central hepatobiliary tract.
    Osmundson EC; Wu Y; Luxton G; Bazan JG; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):986-94. PubMed ID: 25659885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-Volume Predictors of Esophagitis After Thoracic Stereotactic Body Radiation Therapy.
    Harder EM; Chen ZJ; Park HS; Mancini BR; Decker RH
    Am J Clin Oncol; 2017 Oct; 40(5):477-482. PubMed ID: 26017483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study of 55 Patients.
    Bhandari RP; Stanford JD; Packianathan S; Duggar WN; Kanakamedala MR; Zhang X; Giri SP; Kumar PP; Harrell LM; Mangana SH; Yang C; Vijayakumar S
    Oncology; 2016; 91(4):194-204. PubMed ID: 27427761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal toxicity from high-dose, single-fraction paraspinal stereotactic radiosurgery.
    Cox BW; Jackson A; Hunt M; Bilsky M; Yamada Y
    Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e661-7. PubMed ID: 22572079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Esophageal tolerance to high-dose stereotactic ablative radiotherapy.
    Abelson JA; Murphy JD; Loo BW; Chang DT; Daly ME; Wiegner EA; Hancock S; Chang SD; Le QT; Soltys SG; Gibbs IC
    Dis Esophagus; 2012; 25(7):623-9. PubMed ID: 22168251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Body Radiation Therapy Boost After Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Dose Escalation Study.
    Hepel JT; Leonard KL; Safran H; Ng T; Taber A; Khurshid H; Birnbaum A; ; Wazer DE; DiPetrillo T
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1021-1027. PubMed ID: 27745983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.